PMC-005

N/A

Report date: 2023/08/03 16:22:04

Base Information

Drug NamePMC-005
Drug Alias NamePMC-005PMC-005BL
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEpidermal growth factor receptor variant III antagonists
TargetsEpidermal growth factor receptor variant III
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmabcine
China Registration ClassN/A

Develop Information

Active CompaniesPharmabcine
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A